Ujjal K. Mallick

Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer

Ujjal K. Mallick, Clive Harmer, B. Yap et al. · New England Journal of Medicine · 2012 · 616 citations · Full text

Medicine, Oncology, Pharmacology +11

Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial

Hakim‐Moulay Dehbi, Ujjal K. Mallick, Jonathan Wadsley et al. · The Lancet Diabetes & Endocrinology · 2018 · 141 citations · Full text

Medicine, Nuclear Medicine, Oncology +14

The Revised American Thyroid Association Management Guidelines 2009 for Patients with Differentiated Thyroid Cancer: an Evidence-Based Risk-Adapted Approach

Ujjal K. Mallick · Clinical Oncology · 2010 · 39 citations

Medicine, Endocrinology, Oncology +13

Pilot of <i><scp>BRAF</scp></i> mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology

Samantha Johnson, Steven Hardy, Catherine C. Roberts et al. · Cytopathology · 2014 · 38 citations

Medicine, Oncology, Pathology +17

Thyroidectomy with or without postoperative radioiodine for patients with low-risk differentiated thyroid cancer in the UK (IoN): a randomised, multicentre, non-inferiority trial

Ujjal K. Mallick, Kate Newbold, Matthew Beasley et al. · The Lancet · 2025 · 36 citations · Full text

Medicine, Oncology, Surgery +11